Analysis of the Application of Model-informed Drug Development in Pediatric Drug Development Taking Rivaroxaban Granules for Oral Suspension as an Example
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 57 | 57 |
| PDF downloads | 0 | 0 | 10 | 10 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|